Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Auris Nasus Larynx ; 37(6): 669-75, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20399580

ABSTRACT

OBJECTIVE: The aim of this study is to evaluate the usefulness of high-resolution computed tomography (HRCT) densitometry in the diagnosis of otosclerosis and to investigate the relationship between CT densitometry and audiometry. METHODS: HRCT findings and audiometry were compared among 34 patients (34 ears, the otosclerosis group) with surgically confirmed otosclerosis between January 2007 and December 2007 and 33 patients (33 opposite normal ears, the control group) with facial paralysis diagnosed at the same period of time. Seven regions of interest (ROI) were set manually around the otic capsule on the axial slice of 0.75-mm-thick CT image. The mean CT values of these seven regions were measured. In each ROI, the mean CT value of the otosclerosis group and that of the control group were compared. Based on the CT findings, the ears with otosclerosis were classified into two groups: Group A showed no pathological CT findings; Group B showed low density around the cochlea. In the otosclerosis group, the relationship between the findings of CT and the results of audiometry was analyzed. RESULTS: The mean CT values in the area posterior to the oval window and anterior to the oval window were significantly lower for the otosclerosis group compared with the control group (the former t=-2.030, p=0.046; the latter Z=-4.979, p<0.01). Group A consisted of 30 patients, 7 of which (23.33%) exhibited conductive hearing loss, and 23 of which (76.67%) exhibited mixed hearing loss; Group B had 4 patients, all with mixed hearing loss. For the otosclerosis group, the mean CT value in the area posterior to the oval window was positively correlated with the mean air conduction threshold (r=0.4273, p=0.0117) and with the mean air-bone gap (r=0.3995, p=0.0192). CONCLUSION: Quantitative evaluation of CT with slices less than 1mm in thickness may provide important information for the diagnosis and assessment of otosclerosis which are unattainable through other methods.


Subject(s)
Audiometry/standards , Densitometry/standards , Otosclerosis/diagnosis , Tomography, X-Ray Computed/methods , Tomography, X-Ray Computed/standards , Adolescent , Adult , Child , Female , Hearing Loss, Conductive/etiology , Hearing Loss, Mixed Conductive-Sensorineural/etiology , Humans , Male , Middle Aged , Otosclerosis/complications
2.
Article in Chinese | MEDLINE | ID: mdl-19856497

ABSTRACT

OBJECTIVE: To research the trichomonacidal effect of secnidazole benzoate in vitro. METHODS: Trichomonas vaginalis was cultured in liver extract medium in 96-well microplate. The culture suspension of Trichomonas vaginalis was divided into four groups: secnidazole benzoate, secnidazole, metronidazole and control, with medium as blank control. MTT colorimetric assay was applied to determine the inhibitory effect of secnidazole benzoate on the proliferation of Trichomonas vaginalis. The culture suspension was transferred into test tubes and divided into same groups to observe inhibitory effect by the classical microscopic counting method. RESULTS: After 24 h incubation, the proliferation of the parasites was concentration-dependent by secnidazole benzoate (t = 9.02, P < 0.01) at the concentration ranges from 0.15 microg/ml to 20.0 microg/ml with a relative inhibition rate (%) of 14.6, 28.7, 31.3, 60.4, 89.0, 89.2, 95.6, and 100.0 for MTT colorimetric assay, and 18.2, 31.1, 39.7, 68.8, 84.6, 90.1, 94.6, and 100.0 for counting method, respectively. In the period of 6-24 h incubation, the inhibition was in a time-dependent manner. The minimum sterilizing concentration and the minimum inhibitory concentration were 20 microg/ml and 0.15 microg/ml respectively. CONCLUSION: Secnidazole benzoate shows a similar trichomonacidal effect to metronidazole and secnidazole.


Subject(s)
Antitrichomonal Agents/pharmacology , Benzoates/pharmacology , Metronidazole/analogs & derivatives , Trichomonas vaginalis/drug effects , Animals , In Vitro Techniques , Metronidazole/pharmacology , Parasitic Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...